Prostate Oncology

PhaseV Survey Highlights Clinical Trial Workflow Delays

Boston, Massachusetts, August 17, 2026 PhaseV, an artificial intelligence and machine learning company focused on clinical development, has announced...

By cGxPwire Editor
August 18, 2026

Bio-Pharma

Galmed Reports Aramchol Data in Prostate Cancer Models

Ramat Gan, Israel, August 17, 2026 Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology...